KMM Technologies
All insights
EnterpriseTuesday, July 7, 2026

Certara teams with NVIDIA to put BioNeMo agents into drug development

Certara is embedding NVIDIAs BioNeMo Agent Toolkit into its drug development platform, letting agents reason over validated models to optimize dosing, simulate trials and prepare regulatory ready evidence while keeping scientists in the loop.

Read the original source
$ part of the KMM daily AI analysis · published automatically